Navigation Links
A New Test Developed to Identify Suspected Bowel Cancer Patients

Researchers have announced a new test to identify patients who develop bowel cancer as they have a particular gene that could be at fault is unveiled today//.

An Edinburgh University team conducted the test study, and they presented their report in the New England Journal of Medicine. They explained that the tests would help to make certain that these patients could then get the best treatment and will help identify relatives with the same mutation who might have a great increase in the risk of cancer.

The researchers said that around 20,000 people in the general population are thought to have this exacting class of genetic defect, which is associated with a very high risk of cancer. They explained that the biggest challenge was to identify these people, so as to start preventive measures before the disease kicks in or very early in its stage, so as to have a much higher rates of success in controlling it. It was explained that this study that has been reported was a significant step towards this goal.

The researchers explained that the team had developed the test in a long-term study that involved 870 patients, primarily focusing on the faults in three genes, MLH1, MSH2 and MSH6, which are considered responsible for proteins that help to prevent the DNA damage that are linked with tumour development.

The findings of the team showed that 38, about4% of the patients had faulty genes, almost twice as many as suggested by previous estimates. Prof Malcolm Dunlop, one of the researcher said, 'In the long term, we hope the results of this study will help identify all bowel cancer patients who carry one of these gene faults and then offer tests to their relatives who have not yet developed cancer, so that we can prevent the development of cancer.'

Prof Alex Markham, the chief executive of Cancer Research UK, said: 'These are very valuable findings that will help scientists better understand the process of bowel cancer development, particularly in people who are diagnosed at a young age.'


'"/>




Related medicine news :

1. Scientists Developed Map For Brain Molecular Communities
2. Scientists Developed Cheap Way To Assess Sleep
3. Diabetic Friendly Egg Developed In India
4. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
5. Cervical Cancer Vaccine To Be Developed In India
6. Anti-Microbial Coating For Use Over Biomedical Devices Developed
7. Cure for Osteoarthritis To Be Developed
8. Mice With Human Thought Processes Could Be Developed In The Future
9. Viagra Pill For Women To Be Developed
10. Male Contraceptive Pill Being Developed By Berlin Pharmaceutical
11. New Fertility Predictor Test Developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... Kansas City, MO (PRWEB) , ... May 25, 2016 , ... ... professional, collegiate, and amateur athletics, The National Center for Drug Free Sport (Drug Free ... Drug Free Sport”. This conference, to be held July 12 – 13 in Kansas ...
(Date:5/25/2016)... ... May 25, 2016 , ... A new update to ... motion capture, all by utilizing a common Wi-Fi network and a mobile device. When ... from any location with Wi-Fi, and use a mobile device to control the recording. ...
(Date:5/25/2016)... ... , ... According to an article published April 14th on Bioscience ... against common bacteria and protect against surgical site infections. The article explains that this ... even safer and could further reduce the risk of surgery related complications. The ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Horizon Foundation for New ... initiative to improve oral health-related awareness, education, prevention and treatment for young people. ... and promote best practices in 10 New Jersey counties where dental health needs ...
(Date:5/25/2016)... ... , ... The Bank of America Charitable Foundation has awarded a grant to ... pathway to employment and successful careers in healthcare. On Wednesday, May 4th, Rick Bridwell, ... CEO of Medisend, parent organization and home of the General Myers Veterans Program. ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... , May 25, 2016 According ... by Type (3D, 2D, 4D), by Therapeutic Area (Oncology, ... End User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast ... global Medical Animation Market for the forecast period of ... USD 301.3 Million by 2021 from USD 117.3 Million ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, ... Therawis bedient dringenden Bedarf ... QIAGEN N.V. (NASDAQ: QGEN ; ... Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur ... eingegangen zu sein. Ein erstes Projekt wird die ...
Breaking Medicine Technology: